Akers Biosciences Inc. (AKER)

[knuts4oe]

Interesting to note that while MYMD will remain a wholly owned subsidiary of Akers Bio until Spring, any significant news about MYMD will likely affect the price of AKER.
In that regard the merger agreement includes a provision for Milestone payments to MYMD stockholders if Akers Bio stock price reaches certain levels. The 1st Milestone payment of $20 million would be called for if "for at least 10 trading days during any 20 consecutive trading day period during the Milestone Period" the market capitalization of Akers "is equal to or greater than $500 million". With the current outstanding shares of AKER that would occur with AKER at $28 a share.
Another $10 million would need to be paid at $750 market capitalization, and $25 million at $1 billion, and $25 million for each additional $1 billion increase.
All of these payments can be made in Akers common stock!